MatsukiyoCocokaraMSMKF +8.13%91 Return-on-Tangible-Equity is 12.87% as of Mar. 2026, which is 3% above its 10-year median of 12.47. GuruFocus rates MSMKF with a GF Score™ of 91/100 and a GF Value™ of $20.73 (Significantly Undervalued). Among 582 Healthcare Providers & Services companies, MatsukiyoCocokara ranks better than 58.76% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. MatsukiyoCocokara's annualized net income for the quarter that ended in Mar. 2026 was $332 Mil. MatsukiyoCocokara's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $2,583 Mil. Therefore, MatsukiyoCocokara's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 12.87%.
The historical rank and industry rank for MatsukiyoCocokara's Return-on-Tangible-Equity or its related term are showing as below:
MSMKF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.45 Med: 12.47 Max: 14.42
Current: 14.06
During the past 13 years, MatsukiyoCocokara's highest Return-on-Tangible-Equity was 14.42%. The lowest was 9.45%. And the median was 12.47%.
MSMKF's Return-on-Tangible-Equity is ranked better than 58.76% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs MSMKF: 14.06
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
MatsukiyoCocokara Return-on-Tangible-Equity Related Terms
MatsukiyoCocokara Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for MatsukiyoCocokara's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, MatsukiyoCocokara's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MatsukiyoCocokara Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MatsukiyoCocokara's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where MatsukiyoCocokara's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 12.87% mean?
MatsukiyoCocokara (MSMKF) has a Return-on-Tangible-Equity of 12.87% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MatsukiyoCocokara and its competitors. This is near median its historical median of 12.47. Over the past decade, MatsukiyoCocokara's Return-on-Tangible-Equity has ranged from 9.45 to 14.42. According to the industry distribution chart, MatsukiyoCocokara ranks #240 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 41.2%.
Is MatsukiyoCocokara's Return-on-Tangible-Equity too high?
MatsukiyoCocokara's current Return-on-Tangible-Equity of 12.87% is near median its 10-year median of 12.47. Over the past 10 years, this metric has ranged from a low of 9.45 to a high of 14.42. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.07. MatsukiyoCocokara's value of 12.87% is 27.9% above this industry median. Based on the distribution chart, MatsukiyoCocokara ranks #240 out of 582 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MatsukiyoCocokara has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MatsukiyoCocokara's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MatsukiyoCocokara ranks #240 out of 582 companies for Return-on-Tangible-Equity. This puts MatsukiyoCocokara in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.07. MatsukiyoCocokara's value of 12.87% is 27.9% above this benchmark. Historically, MatsukiyoCocokara's own Return-on-Tangible-Equity has ranged from 9.45 to 14.42 over the past decade. While the company's 10-year median is 12.47 vs. the industry median of 10.07, MatsukiyoCocokara has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MatsukiyoCocokara's current Return-on-Tangible-Equity of 12.87% is 27.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MatsukiyoCocokara and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MatsukiyoCocokara's current Return-on-Tangible-Equity is 12.87%, which is near median its own 10-year median of 12.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MatsukiyoCocokara stock overvalued right now?
Based on GuruFocus' analysis, MatsukiyoCocokara (MSMKF) is currently considered Significantly Undervalued. The stock's GF Value™ is $20.73, compared to a current price of $14.60 — trading 29.6% below its estimated fair value. The current Return-on-Tangible-Equity is 12.87%, which is near median its 10-year median of 12.47 and 27.9% above the Healthcare Providers & Services industry median of 10.07. MatsukiyoCocokara's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For MatsukiyoCocokara (MSMKF), the current Return-on-Tangible-Equity is 12.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MatsukiyoCocokara (MSMKF) Overvalued in 2026?
Based on GuruFocus' analysis, MatsukiyoCocokara stock appears to be undervalued.
The current stock price of $14.60 is trading 29.6% below its estimated GF Value™ of $20.73.
GuruFocus considers MatsukiyoCocokara to be Significantly Undervalued.
Key valuation signals for MSMKF:
Return-on-Tangible-Equity: 12.87% (near median its 10-year median of 12.47)
GF Value™: $20.73 vs. price of $14.60 (29.6% below fair value)
Industry Position: 27.9% above the Healthcare Providers & Services median (#240 of 582)
No single metric tells the full story. See the MSMKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MatsukiyoCocokara & Co operates retail drugstores and insurance dispensing pharmacies in Japan. The company's main segments are the Matsumotokiyoshi Group Business, focused on stores under the Matsumotokiyoshi brand; the Cocokara Fine Group Business, centered on Cocokara Fine stores; and the Management Support Business, which procures products, oversees group operations, and manages indirect functions such as advertising and promotion. It generates the majority of its revenue from the Matsumotokiyoshi Group Business segment.
91GF Score
Get the complete analysis for MSMKF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSMKF has been successfully added to your 
